Skip to main content
. 2012 Aug 15;2012(8):CD008465. doi: 10.1002/14651858.CD008465.pub2

Moadel 2007.

Study characteristics
Methods Study design: RCT
Number randomized: 164; 108 to a yoga exercise group and 56 to the control group
Study start and stop dates: 2001 to 2005
Length of intervention: 12 weeks
Length of follow‐up: 1, 3, and 6 months
Participants Type cancer: breast cancer, stage of disease:
  • exercise group: Stage I, 42%; Stage II, 36%; Stage III, 17%; Stage IV, 5%

  • control group: Stage I, 50%; Stage II, 38%; Stage III, 12%; Stage IV, 0%


Time since cancer diagnosis, mean (SD, range) years:
  • exercise group: 1.15 (1.14, 0.06 to 4.06) years

  • control group: 0.98 (1.13, 0.03 to 4.70) years


Time in active treatment: receiving chemotherapy, %:
  • exercise group: at baseline, 30%; at 3 months, 36%

  • control group: at baseline, 23%; at 3 months, 27%


Randomization was stratified by treatment status
Inclusion criteria:
  • ≥ 18 years old

  • new/recurrent breast cancer (Stages I to III) diagnosis within previous 5 years

  • high performance status (ECOG performance status of < 3)

  • ability to speak English or Spanish


Eligibility criterion related to interest or ability, or both, to exercise:
  • not actively practicing yoga


Exclusion criteria: none reported
Gender: female
Current age, mean (SD, range) years:
  • exercise group: 55.11 (10.07, 32 to 75) years

  • control group: 54.23 (9.81, 28 to 71) years


Age at cancer diagnosis: not reported
Ethnicity/race, %:
  • exercise group: African‐American, 42%; Hispanic, 30%; non‐Hispanic white, 22%; other, 6%

  • control group: African‐American, 43%; Hispanic, 34%; non‐Hispanic white, 23%; other, 0%


Education level:
  • exercise group: high school, 69%; college/graduate, 31%

  • control group: high school, 89%; college/graduate, 11%


SES: not reported
Employment status: not reported
Comorbidities: not reported
Past exercise history: not reported
On hormone therapy, %:
  • exercise group: at baseline, 24%; at 3 months, 36%

  • control group: at baseline, 41%; at 3 months, 50%

Interventions 108 participants assigned to exercise group, consisting of yoga with each session including:
  • physical stretches and poses

  • breathing exercises

  • meditation


All exercises were done in a seated or reclined position
Type exercise (aerobic/anaerobic): aerobic
Intensity of experimental exercise intervention: mild
Frequency: once per week, but participants were allowed to attend more than 1 session per week and asked to practice yoga at home
Duration of sessions: 90 minutes
Duration of program: 12 weeks
Total number of exercise sessions: 12 sessions
Facility: facility and home
Professionally led: not reported
56 participants assigned to control group, including:
  • waiting list


Adherence: 26 (31%) participants did not attend any classes, but 8 reported practicing yoga at home at least a few times per week. The mean number of classes attended by active class participants was 7.00 (SD 3.80) classes. Of 59 participants reporting data, 61% practiced yoga at home at least a few times per week
Contamination of control group: not reported
Outcomes No primary outcome was identified. QoL outcomes included:
  • global QoL, measured using the FACT‐G and subscales of

    • PWB

    • functional well‐being

    • EWB

    • SWB

  • fatigue, assessed using the FACIT‐F

  • spiritual well‐being, assessed using the FACIT‐Sp

  • mood, assessed using subscales of the POMS


Outcomes were measured at baseline and 12 weeks:
  • exercise group: n = 84 at baseline, n = 84 at 12 weeks

  • control group: n = 44 at baseline, n = 44 at 12 weeks


Subgroup analysis: by treatment status
Adverse events: none reported
Notes Country: US
Funding: National Cancer Institute, Langeloth Foundation
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Unclear risk Generation of allocation sequence was not described
Allocation concealment (selection bias) Unclear risk Whether the treatment assignment was concealed from study personnel and participants was not described
Blinding of participants and personnel (performance bias)
All outcomes High risk Owing to the nature of the intervention, it was not possible to conceal allocation to the intervention from the participants
Blinding of outcome assessment (detection bias)
All outcomes High risk Study personnel and outcome assessors were not masked or blinded to the study interventions
Incomplete outcome data (attrition bias)
All outcomes High risk Investigators stated that they used an "intention‐to‐treat approach" but it is unclear how the 24 drop‐outs in the exercise arm and the 12 drop‐outs in the control arm were handled
Selective reporting (reporting bias) Low risk There appears to be no selective reporting of outcomes
Other bias Low risk The trial appears to be free of other problems that could put it at a high risk of bias